市場調查報告書

注射型藥物輸送設備的全球市場的未來預測

Injectable Drug Delivery Market: By Devices (Auto Drug Injecting, Pen Injectors, Others); By Drug Formulations (Conventional, Novel ); By Therapeutic Area (Hormonal Disorders, Oncology, Auto-Immune, Others); By Geography - 2018 - 2023

出版商 IndustryARC 商品編碼 622518
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
注射型藥物輸送設備的全球市場的未來預測 Injectable Drug Delivery Market: By Devices (Auto Drug Injecting, Pen Injectors, Others); By Drug Formulations (Conventional, Novel ); By Therapeutic Area (Hormonal Disorders, Oncology, Auto-Immune, Others); By Geography - 2018 - 2023
出版日期: 2018年12月17日內容資訊: 英文
簡介

本報告提供全球注射型藥物輸送設備的市場相關分析,提供整體市場結構和背景情況,主要的推動及阻礙市場要素,各產品種類 (設備,劑型)·各疾病·各地區的市場趨勢預測,市場競爭情勢,近來的資本交易·策略發展的動向,主要企業的簡介等相關調查。

第1章 市場概要

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 比較分析
    • 產品的互相比較
    • 終端用戶的簡介
    • 專利分析
    • 前五名公司的財務分析

第4章 全球注射式藥物輸送設備市場:對市場的影響要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場課題
  • 市場向心力:波特的五力分析

第5章 全球注射式藥物輸送設備市場:策略分析

  • 價值鏈分析
  • 市場機會分析
  • 產品/市場生命週期分析

第6章 全球注射式藥物輸送設備市場:各類型

  • 醫藥品的劑型方法
  • 不同設備
    • 傳統的設備
    • 自動注射設備
    • 自行注射設備
    • 筆型注射器
    • 無針頭注射設備
  • 其他

第7章 全球注射式藥物輸送設備市場:疾病類別

  • 貧血症
  • 糖尿病
  • 多發性硬化症
  • 風濕
  • 克隆氏症
  • 其他

第8章 全球注射式藥物輸送設備市場:各地區

  • 簡介
  • 北美 (加拿大,海地,墨西哥,美國等)
  • 中南美 (阿根廷,巴西,智利,哥倫比亞,委內瑞拉等)
  • 歐洲 (德國,法國,義大利,俄羅斯,西班牙,土耳其,英國等)
  • 亞太地區 (孟加拉,中國,印度,尼泊爾,斯里蘭卡,新加坡,馬來西亞等)
  • 其他的國? (RoW)

第9章 市場熵 (市場變化的方向性)

  • 新產品的銷售
  • 企業合併·收購 (M&A),事業聯盟·合作,合資企業 (JV)

第10章 企業簡介 (概要,財務分析,SWOT分析,近幾年趨勢,產品系列)

  • Becton Dickinson and Company (BD)
  • Baxter International Inc.
  • Consort Medical PLC
  • Crossject SA
  • Eli Lilly and Company
  • Elcam Medical
  • Novo Nordisk
  • Owen Mumford Ltd
  • Sanofi
  • Schott AG
  • Terumo Corporation
  • Ypsomed Holding AG
  • 其他

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The global injectable drug delivery market is $15.7B in 2017 and is estimated to grow at a CAGR of 8.53% during 2018-2023. Conventional injection devices holds the highest market share with 87% and generated revenue of 13.1B and is projected to grow with a CAGR of 7.37%. Changing healthcare models, a growing number of patients are driving the injectable drug delivery market.

What is Injectable drug delivery?

Injectable drug delivery is the injection of drugs in the patient's body using a delivery device. With this it has become relatively easy allowing patients to administer drugs at home without medical assistance.

What are the major applications for Injectable drug delivery?

Injectable drug delivery is majorly used for different conditions that include hepatitis C, cystic fibrosis, pain, autoimmune diseases, Wilson's disease, hormonal imbalance, hemophilia, and ribose-5-phosphate isomerase deficiency. It also helps in administering drugs in unconscious and comatose patients.

Market Research and Market Trends of Injectable drug delivery

Advancements in technological processes have resulted in the generation of improved and enhanced devices, as well as equipment that is tailor-made and specific to different categories of patient care. In addition, technological innovations like dual-injectable have further enhanced the method of drug delivery and the development of the biologics market has led to an increase in the demand for these injectable.

SmartDose platform is designed to easily integrate into a patient's lifestyle. The single-use, electronic wearable injector stick to the patient's body usually on the abdomen. It was designed for patient comfort and simplicity.

Component manufacturers continue to develop sophisticated packaging components and delivery systems to support the requirements of complex drug products. Drive toward cleaner and more secure primary containment systems that avoid interaction with the drug product and maintain the drug product's purity and effectiveness over time.

Who are the Major Players in Injectable drug delivery market?

The companies referred in the market research report includes Baxter international, Terumo Corp, Schott AG, SHL group, Owen Mumford ltd, Sanofi, Novo nordix.

What is our report scope?

The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2024.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy - M's, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1. Market Overview

2. Executive Summary

3. Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. End user profiling
    • 3.2.3. Patent Analysis
    • 3.2.4. Top 5 Financials Analysis

4. Global Injectable Drug Delivery - Market Forces

  • 4.1. Market Drivers
    • 4.1.1. Inherent Use Case Scenario of IDD Devices With Biologics
    • 4.1.2. Increase in Global Diabetic Population and Usage of Insulin Pens
    • 4.1.3. Others
  • 4.2. Market Constraints
    • 4.2.1. Infection Risks And Government Laws
    • 4.2.2. Others
  • 4.3. Market Challenges
    • 4.3.1. Higher Manufacturing Standards Needed to Avoid Product Recalls
    • 4.3.2. Others
  • 4.4. Attractiveness of the Industry
    • 4.4.1. Power of Suppliers
    • 4.4.2. Power of Customers
    • 4.4.3. Threat of New entrants
    • 4.4.4. Threat of Substitution
    • 4.4.5. Degree of Competition

5. Global Injectable Drug Delivery Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Opportunities Analysis
  • 5.3. Product/Market Life Cycle Analysis

6. Global Injectable Drug Delivery Market - By Type

  • 6.1. Pharmaceutical Drug Formulations
  • 6.2. By Device
    • 6.2.1. Conventional Devices
    • 6.2.2. Auto Injector Devices
    • 6.2.3. Self Injector Devices
    • 6.2.4. Pen Injectors
    • 6.2.5. Needle Free Injector Devices
  • 6.3. Others

7. Global Injectable Drug Delivery Market - By Type of Diseases

  • 7.1. Anemia
  • 7.2. Diabetes
  • 7.3. Multiple sclerosis
  • 7.4. Rheumatoid
  • 7.5. Crohn's
  • 7.6. Others

8. Global Injectable Drug Delivery Market -Geographic Analysis

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. Canada
    • 8.2.2. Haiti
    • 8.2.3. Mexico
    • 8.2.4. USA
    • 8.2.5. Others
  • 8.3. South & Central America
    • 8.3.1. Argentina
    • 8.3.2. Brazil
    • 8.3.3. Chile
    • 8.3.4. Colombia
    • 8.3.5. Venezuela
    • 8.3.6. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. Italy
    • 8.4.4. Russia
    • 8.4.5. Spain
    • 8.4.6. Turkey
    • 8.4.7. U.K
    • 8.4.8. Others
  • 8.5. APAC
    • 8.5.1. Bangladesh
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Nepal
    • 8.5.5. Srilanka
    • 8.5.6. Singapore
    • 8.5.7. Malaysia
    • 8.5.8. Others
  • 8.6. ROW

9. Market Entropy

  • 9.1. New Product Launches
  • 9.2. M&As, Collaborations, JVs and Partnerships

10. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio)

  • 10.1. Becton Dickinson and Company (BD)
  • 10.2. Baxter International Inc.
  • 10.3. Consort Medical PLC
  • 10.4. Crossject SA
  • 10.5. Eli Lilly and Company
  • 10.6. Elcam Medical
  • 10.7. Novo Nordisk
  • 10.8. Owen Mumford Ltd
  • 10.9. Sanofi
  • 10.10. Schott AG
  • 10.11. Terumo Corporation
  • 10.12. Ypsomed Holding AG
  • 10.13. Others

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top